This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Sep 27;367(13):1266; author reply 1267.

doi: 10.1056/NEJMc1209905.

Protocols, physiology, and trials of hydroxyethyl starch

Daniel Chappell, Matthias Jacob

PMID: 23013090
DOI: 10.1056/NEJMc1209905

Comment

Protocols, physiology, and trials of hydroxyethyl starch

Daniel Chappell et al. N Engl J Med. 2012.

. 2012 Sep 27;367(13):1266; author reply 1267.

doi: 10.1056/NEJMc1209905.

Authors

Daniel Chappell, Matthias Jacob

PMID: 23013090
DOI: 10.1056/NEJMc1209905

No abstract available

PubMed Disclaimer

Comment on

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group. Perner A, et al. N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27. N Engl J Med. 2012. PMID: 22738085 Clinical Trial.

Similar articles

Protocols, physiology, and trials of hydroxyethyl starch.
Wise R, Fourie C, Richards GA. Wise R, et al. N Engl J Med. 2012 Sep 27;367(13):1266-7; author reply 1267. doi: 10.1056/NEJMc1209905. N Engl J Med. 2012. PMID: 23013091 No abstract available.
Protocols, physiology, and trials of hydroxyethyl starch.
von Heymann C, Sander M, Spies CD. von Heymann C, et al. N Engl J Med. 2012 Sep 27;367(13):1265-6; author reply 1267. doi: 10.1056/NEJMc1209905. N Engl J Med. 2012. PMID: 23013089 No abstract available.
Protocols, physiology, and trials of hydroxyethyl starch.
Magder S. Magder S. N Engl J Med. 2012 Sep 27;367(13):1265; author reply 1267. doi: 10.1056/NEJMc1209905. N Engl J Med. 2012. PMID: 23013088 No abstract available.
Prolonged Field Care Working Group Fluid Therapy Recommendations.
Baker BL, Powell D, Riesberg J, Keenan S. Baker BL, et al. J Spec Oper Med. 2016 Spring;16(1):112-7. J Spec Oper Med. 2016. PMID: 27045508 Review.
Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
Patel A, Brett SJ. Patel A, et al. Br J Hosp Med (Lond). 2013 Mar;74(3):178. doi: 10.12968/hmed.2013.74.3.178. Br J Hosp Med (Lond). 2013. PMID: 23665793 Review. No abstract available.

See all similar articles

Cited by

Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.
Müller RG, Haase N, Wetterslev J, Perner A. Müller RG, et al. Intensive Care Med. 2013 Nov;39(11):1963-71. doi: 10.1007/s00134-013-3090-x. Epub 2013 Sep 14. Intensive Care Med. 2013. PMID: 24037226 Clinical Trial.
Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union.
Adamik KN, Yozova ID. Adamik KN, et al. Front Vet Sci. 2019 Jan 18;5:336. doi: 10.3389/fvets.2018.00336. eCollection 2018. Front Vet Sci. 2019. PMID: 30713845 Free PMC article. Review.
Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.
Haase N, Wetterslev J, Winkel P, Perner A. Haase N, et al. Intensive Care Med. 2013 Dec;39(12):2126-34. doi: 10.1007/s00134-013-3111-9. Epub 2013 Oct 1. Intensive Care Med. 2013. PMID: 24081433 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information